Skip to content

Building 7, Ipsen Biopharm Ltd, Ash Road North, Wrexham Industrial Estate, Wrexham, LL13 9UF

P/2026/0487Caniatâd Cynllunio Llawn / Full planning permissionAwaiting decision
Full
Approximate location: the centre of the postcode, not the exact property.

Proposal

FORMATION OF LANDSCAPED AND PEDESTRIANISED AREA WITH ASSOCIATED WORKS

Received
28 July 2026
Decision level
Delegated (officer decision)
Ward
Holt/Holt
  1. Received28 Jul
  2. Validated30 Jul
  3. Consult.
  4. Target
  5. Decided

About this application

This is a full planning application at BUILDING 7, IPSEN BIOPHARM LTD, ASH ROAD NORTH, WREXHAM INDUSTRIAL ESTATE, WREXHAM, LL13 9UF. Wrexham has handled 942 applications of this type. It has been with the council since 28 July 2026 and is still awaiting a decision. There are no previous applications recorded at this address. In the past year there have been 21 applications across Holt/Holt. We hold 1,008 applications in total for the LL13 postcode area.

95% of full applications at Wrexham County Borough Council were approved. Across all application types, the council typically decides in about 10 weeks (median).

Based on decided applications received in the last 3 years.See what's approved near your address

Application details

Postcode
LL13 9UF
Application type
Caniatâd Cynllunio Llawn / Full planning permission
Scale / size
Small
Parish
Abenbury/Abenbury

Planning application dates

Date validated
30 July 2026
Application expires
24 September 2026

Planning decision

Statutory period
56 days

Additional information

Documents
29

Site constraints

Checking the site
2/3
Council recordsAppealsFlood risk

Source: Wrexham

Track this application

Get email alerts when there is a planning decision or status change.

Get email alerts near LL13

New planning applications delivered to your inbox daily.

Around this site

For applicants and trades

What's been approved on your street?

See what the council approved and refused near this address for the project you have in mind, and the rules that apply here.

Get The Signal Report